Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer. (Q53665742)
Jump to navigation
Jump to search
scientific article published in April 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer. |
scientific article published in April 1994 |
Statements
Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer. (English)
I F Tannock
M J Moore
D Osoba
K Murphy
A Armitage
B Findlay
C Coppin
A Neville
P Venner
J Wilson
1 April 1994
12
4
689-694